Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology

Thrombosis Clinical Trials

A listing of Thrombosis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 3 4 5 6 Last 

Alabama

Birmingham Alabama 35294

A clinical research study of SENTRY IVC Filter for the treatment of Pulmonary Embolism or Deep Vein Thrombosis

Arizona

Glendale Arizona 85306

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Arkansas

Little Rock Arkansas 72205

A clinical study for patients with HeartMate II Pump Thrombosis

Little Rock Arkansas 72202

A clinical research study of Apixaban for the treatment of Thromboembolism

Little Rock Arkansas 72202-3500

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

California

UPDATED

La Jolla California 92037

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Los Angeles California 90027-6089

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Los Angeles California 90027-6089

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Los Angeles California 90025

Patients are needed to participate in a clinical research study to evaluate Varicose Veins, MTHFR, Venous Disease or Thrombosis

Orange California 92868

A clinical research study of Apixaban for the treatment of Thromboembolism

View More ▼

Orange California 92868

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Stanford California 94305

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Connecticut

Danbury Connecticut 06810

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Hartford Connecticut 06106

A clinical research study of Apixaban for the treatment of Thromboembolism

Norwich Connecticut 06360

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Delaware

Newark Delaware 19713

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Newark Delaware 19718

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

District of Columbia

Washington District of Columbia 20010

A clinical research study of Apixaban for the treatment of Thromboembolism

Washington District of Columbia 20007

A clinical research study of Apixaban for the treatment of Thromboembolism

Florida

Boca Raton Florida 33486

Patients are needed to participate in a clinical research study of Aspirin and Ticagrelor to evaluate Saphenous Vein Graft Disease

Orlando Florida 32803

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Tampa Florida 33613

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Georgia

Atlanta Georgia 30322

A clinical research study of Apixaban for the treatment of Thromboembolism

UPDATED

Columbus Georgia 31904

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Illinois

Chicago Illinois 60611

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Hinsdale Illinois

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Winfield Illinois 60190

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Indiana

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Indianapolis Indiana 46260

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Kentucky

Florence Kentucky 41042

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Louisville Kentucky 40202

A clinical research study of Apixaban for the treatment of Thromboembolism

Maine

Portland Maine 04102

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

UPDATED

Rockport Maine 04856

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Massachusetts

Boston Massachusetts

A clinical trial to evaluate treatments for patients with Deep Venous Thrombosis, Pulmonary Embolism or D-dimer

Michigan

Ann Arbor Michigan 48105

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

UPDATED

Detroit Michigan 48202

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Detroit Michigan 48201-2196

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Detroit Michigan 48202

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Minnesota

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Missouri

Kansas City Missouri 64108

A clinical research study of Apixaban for the treatment of Thromboembolism

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Montana

UPDATED

Butte Montana 59701

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Nebraska

Lincoln Nebraska 68510-2494

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

New Jersey

New Brunswick New Jersey 08901

A clinical research study of Apixaban for the treatment of Thromboembolism

Teaneck New Jersey 07666

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

New York

New Hyde Park New York 11040

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

First 1 2 3 4 5 6 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.